Medical research

How a mutated gene wreaks havoc on white matter

An inherited disease of myelin marked by slow, progressive neurological impairment is caused by mutations of a gene that controls lipid metabolism, a finding that may shed insight into mechanisms to control the course of ...

Medications

FDA approves Darzalex Faspro for treating multiple myeloma

The U.S. Food and Drug Administration has approved Johnson & Johnson's Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation ...

Cardiology

Shining new light on vascular diseases in diabetics

Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is caused by narrowing of the arteries as a result of plaque buildup. The ...

Oncology & Cancer

FDA approves first-line therapy for peripheral T-cell lymphoma

(HealthDay)—The U.S. Food and Drug Administration on Friday expanded approval for the use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with specific types of peripheral ...

Diabetes

Deprivation tied to foot disease with new type 2 diabetes

(HealthDay)—Social deprivation is associated with diabetes-related foot disease (DFD) in patients newly diagnosed with type 2 diabetes, according to a study published online Jan. 22 in Diabetes Care.

page 6 from 10